Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Growblox Sciences Inc (OP: GBLX )

0.0775 USD UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Growblox Sciences Inc

< Previous 1 2 3 4 5 6 Next >
North American Spending on Legal Cannabis is Expected to Grow to USD 47 Billion by 2027
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery Examining Cannabis-Based, Disease-Modifying Compounds
GB Sciences, Inc. (OTCQB: GBLX) initiates a new project with the Department of Pharmacognosy and Natural Products Chemistry at the National Kapodistrian University of Athens, Greece. Titled: The... 
From PR Newswire
GB Sciences' Drug Development Program Benefits from Establishment of Clear Pathway for Cannabis-Based Drug Approvals and Commercialization
GB Sciences, Inc. (OTCQB: GBLX) has gained momentum in its innovative drug discovery program with the Drug Enforcement Administration (DEA)'s decision to reschedule GW Pharmaceuticals' Epidiolex, from... 
From PR Newswire
Catalent Selected to Provide Oral Delivery Systems for GB Sciences' Proprietary Parkinson's Disease Therapies
GB Sciences, Inc. (OTCQB: GBLX) and Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,... 
From PR Newswire
Jobs and Salaries in the Legal Cannabis Industry Continues to Grow
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals
The new license provides access to the largest growing sectors in the cannabis industry. Multiple new brands for both medical and recreational markets being prepped for retail sales. 
From PR Newswire
GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies"
GB Sciences, Inc. (OTCQB:GBLX) has mobilized cannabis industry thought leaders to discuss both the immense potential for cannabis-based therapies and the challenges of delivering on their medical... 
From PR Newswire
CannabisNewsAudio – Earth Science Tech, Inc. (ETST) at the Vanguard of the Cannabinoid Therapeutics Surge
From CannabisNewsWire
GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary
GB Sciences, Inc. (OTCQB: GBLX) announces that Dr. Andrea Small-Howard will be moderating the panel discussion which kicks-off the "Cannabis Is Medicine Track" and explores important Research... 
From PR Newswire
Growing Need for Medical and Recreational Cannabis Looks to Continue Globally
FinancialBuzz.com News Commentary 
From PR Newswire
The CBD Bonanza on the Horizon
From PR Newswire
Data Shows the Global Medical Cannabis Usage Continues to Grow
FinancialBuzz.com News Commentary 
From PR Newswire
Data Projects the Canadian Cannabis Market to be Worth Over USD 5 Billion in 2018
FinancialBuzz.com News Commentary 
From PR Newswire
The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership
GB Sciences, Inc. (OTCQB:GBLX) With the first cannabis crop now in production at their high-tech 36,000 square-foot grow facility in Baton Rouge, teams from GB Sciences and the LSU AgCenter are working... 
From PR Newswire
Robust Growth in Cannabidiol (CBD) and Hemp Market Fueling Strong Optimistic Outlook
From PR Newswire
GB Sciences and Louisiana State University Agricultural Center Begins Cultivation of Their First Cannabis Crop
GB Sciences, Inc. (OTCQB: GBLX) and the LSU Agricultural Center (LSU AgCenter), have now commenced operation in the environmentally controlled grow pod. The first plants in production were developed... 
From PR Newswire
Cannabis Market Growth Outpaces Estimates as Global Momentum Grows
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences reports first quarter revenue of $1.3 million with gross profit of $700 thousand compared to revenue of $69,100 for same period last year
For the three months that ended June 30, 2018, GB Sciences, Inc. (OTCQB: GBLX) reported revenue of $1,315,284 and gross profit of $734,719. This compares to revenue and gross profit of $69,100 and... 
From GlobeNewswire News Releases
Legal Cannabis Market is Growing More Competitive as Demand Grows
FinancialBuzz.com News Commentary 
From PR Newswire
Michigan State University's Dr. Norbert Kaminski Begins Pre-Clinical Study of GB Sciences' Neuroprotective Cannabis Compounds For Parkinson's Disease
GB Sciences, Inc. (OTCQB: GBLX) has signed an agreement to initiate research collaborations with Dr. Norbert Kaminski, Professor of Pharmacology & Toxicology at Michigan State University. Dr. Kaminski... 
From PR Newswire
GB Sciences Co-Authors a Peer Reviewed Article Published in the Journal of the American Heart Association Titled: "Cannabinoids, The Heart of the Matter"
GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the publication of a review article co-authored by GB Sciences and key collaborators in the Journal of the American Heart Association, which... 
From PR Newswire
Data Points to the Usage of Legal Cannabis Is on the Rise
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Strengthen Their Current and Future Compliance Programs by Building A Relationship with Adherence Compliance
The new Chief Compliance Officer Program and the SCORE App lay a solid compliance foundation to support GB Sciences’ rapidly maturing expansion plans. 
From GlobeNewswire News Releases
Widespread Legalization is Vaulting Cannabis Business Legitimacy
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Partners with the Colorado Hemp Project to Cultivate and Extract Full Spectrum Hemp Oil from Proprietary Hemp Strains to Open a New Revenue Stream in the Rapidly Growing Hemp Market
GB Sciences, Inc. (OTCQB: GBLX) updates the progress in their efforts to identify, cultivate and extract full spectrum hemp oil from proprietary hemp strains that contain desirable ratios of CBD,... 
From PR Newswire
Data Projects That Nationwide Cannabis Retail Sales to Surpass USD 20 Billion by 2022
FinancialBuzz.com News Commentary 
From PR Newswire
Demand for Cannabis Business Education Is Intensifying
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences One of Ten Companies Named in Important New Canadian Research Publication
Corporate strategy dedicated to scientific medical research, a viable drug development pipeline and a strong Intellectual Properties Patent Portfolio are cited as the key differentiating factors. 
From PR Newswire
Legal Supply Channels Are Expected to Help Grow the Cannabis Market
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Files Patent on Cannabis-based Therapies for the Treatment of Asthma, Urinary Cystitis, Hearing Loss, plus Chronic, Inflammatory and Neuropathic Pain
GB Sciences’ novel therapeutic approach paves the way for the creation of precision medicines derived from the cannabis plant. 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.